ICON, pharma companies layoff workers in Austin to start 2025
Austin-area robotic architecture firm ICON and pharmaceutical company Cassava Sciences combined to layoff over 120 workers ...
Brokerages Set Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Price Target at $347.33
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) has been given an average rating of “Moderate Buy” by the thirteen ratings firms that are presently covering the stock, Marketbeat.com ...
Madrigal Pharmaceuticals’ Rezdiffra Shows Strong Market Growth and Positive Outlook, Justifying Buy Rating
Analyst Jonathan Wolleben of JMP Securities reiterated a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report), with a price target ...
Bank of America Securities Remains a Sell on Madrigal Pharmaceuticals (MDGL)
Bank of America Securities analyst Jason Zemansky maintained a Sell rating on Madrigal Pharmaceuticals (MDGL – Research Report) today and set a ...